Based on his experience from HIV/AIDS patients, Lars Hagberg reviewed the management of treatment-induced infections in patients with T-cell depression.

Elisabeth Celius discussed relapse management and the risk of infections associated with disease-modifying therapy.

Jan Lycke presented early data on antiviral treatment in MS, providing insights into MS care prior to the DMT era.

Due to the extensive use of vaccinations, even a small increased risk of MS or other acquired CNS demyelinating syndromes could have a significant effect on public health. Jette Lautrup Frederiksen presented a systematic literature study on the role of vaccines regarding the risk of MS development and MS relapse.

Peter Sundström discussed the management of risk factors in MS, focussing on infectious agents, in particular EBV.